I. Celik Et Al. , "Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , vol.33, Illinois, United States Of America, 2015
Celik, I. Et Al. 2015. Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , (Illinois, United States Of America).
Celik, I., Mandel, N. M., Gokmen, E., Unal, O. U., Sevinc, A., COŞKUN, H. Ş., ... Buyukberber, S.(2015). Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey . Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America
Celik, Ismail Et Al. "Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey," Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 2015
Celik, Ismail Et Al. "Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America, 2015
Celik, I. Et Al. (2015) . "Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey." Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Ismail Celik Et Al. }, title={Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey}, congress name={Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer}, city={Illinois}, country={United States Of America}, year={2015}}